Building more useful CRISPR/Cas technologies
7 Feb 2022
Since 2013, the CRISPR/Cas9 system has become a widely used tool for genome editing due to its simplicity. Since that time, CRISPR technology has been adapted for diverse applications aside from genome editing, providing versatility comparable to preceding techniques. In the final installment of the CRISPR webinar series, We look to unlock the full potential of this technology.
About the company
GenScript
Founded in 2002 in New Jersey, GenScript Biotech Corporation accelerates innovation in biotech and healthcare by providing researchers and companies with the building blocks needed to develop groundbreaking treatments and products. Guided by its mission to Make People and Nature Healthier Through Biotechnology, and its role as a trusted global leader, GenScript has a team of over 5,700 employees and has served more than 200,000 customers across over 100 countries and regions.
